Skip to search formSkip to main contentSkip to account menu

linotroban

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AcetatesThiophenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
[Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
Combining the structural features of picotamide and linotroban, a series of N,N'-bis-(halogenophenyl)-4-methoxybenzene-1, 3… 
2000
2000
Determination of Efficacy of Linotroban by Inducing a Reduction of Renal Inulin/para-Aminohippuric Acid Clearances with the Thromboxane A2 Mimetic U-46619 in the Conscious Female Rat
Summary Linotroban (CAS 141443-73-4), a potent and selective thromboxane (TXA2) receptor antagonist, is known as a novel… 
1997
1997
Role of ADP and thromboxanes in human thrombus formation in ex vivo models.
Adenosine diphosphate (ADP) and prostaglandin derivatives play important roles in thrombogenesis. Their roles in platelet… 
1997
1997
Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat.
This paper reports the results of experiments designed to determine the effect of linotroban (CAS 141443-73-4) a selective… 
1997
1997
Cisplatin‐induced renal effects and thromboxane A2 receptor blockade
The aim of this study was to evaluate the renal protective effect of linotroban, a thromboxane A2 receptor antagonist, in 25… 
1997
1997
Thromboxane A2 does not mediate angiotensin II-dependent nonischemic peripheral vasoconstriction in healthy men: a pilot study.
It has been suggested that angiotensin II-dependent hemodynamic effects are in part mediated by thromboxane A2 (TXA2). The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)